Search

Your search keyword '"Pinocytosis drug effects"' showing total 590 results

Search Constraints

Start Over You searched for: Descriptor "Pinocytosis drug effects" Remove constraint Descriptor: "Pinocytosis drug effects"
590 results on '"Pinocytosis drug effects"'

Search Results

301. Selective effects of the PKC inhibitors Ro 31-8220 and CGP 41,251 on PMN locomotion, cell polarity, and pinocytosis.

302. Changes in brain microvessel endothelial cell monolayer permeability induced by adrenergic drugs.

303. The coated pit and macropinocytic pathways serve distinct endosome populations.

304. Pinocytic stimulation in Dictyostelium discoideum by gamma-benzene hexachloride.

305. Chloroquine accumulation and alterations of proteolysis and pinocytosis in the rat conceptus in vitro.

306. K252a, a potent inhibitor of protein kinases, promotes the transition of Dictyostelium cells from growth to differentiation.

307. Inhibition of mouse embryonic, yolk sac, and limb-bud functions by the methyl isocyanate metabolite S-(N-methylcarbamoyl)glutathione.

308. Isolation of an inhibitor for the independent mannose 6-phosphate receptor endocytosis of bovine beta-glucuronidase by human fibroblasts.

309. Hydrogen peroxide stimulates endocytosis in cultured bovine aortic endothelial cells.

310. The PKC-inhibitor Ro 31-8220 selectively suppresses PMA- and diacylglycerol-induced fluid pinocytosis and actin polymerization in PMNs.

311. Endo-lysosomal acidification in Dictyostelium discoideum amoebae. Effects of two endocytosis inhibitors: caffeine and cycloheximide.

312. Sodium chloride stress induced morphological and ultrastructural changes in Aspergillus repens.

313. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor-treated cells.

314. Polymyxin B complexes with and cationizes low density lipoproteins. The cause of polymyxin B-induced enhancement of endocytotic catabolism of low density lipoproteins.

315. Stimulation of interleukin-1 alpha and interleukin-1 beta production in human monocytes by protein phosphatase 1 and 2A inhibitors.

316. Protein phosphatase inhibitors okadaic acid and calyculin A alter cell shape and F-actin distribution and inhibit stimulus-dependent increases in cytoskeletal actin of human neutrophils.

317. Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.

318. Analysis of the receptor complement for insulin and insulin-like growth factor I (IGF-I) in the rat visceral yolk sac.

319. Regulation of pinocytosis in murine macrophages by colony-stimulating factors and other agents.

320. [Ultrastructural features of changes in capillaries and atrial cardiomyocytes induced by endotoxin injection].

321. Manipulation of phototransductive membrane turnover by crab photoreceptors in vitro: effects of two protein kinase activators, SC-9 and phorbol ester in the presence of a protein phosphatase inhibitor, okadaic acid.

322. Coumarins: macrophage proteinase production and pinocytosis.

323. Interaction of gelonin with macrophages: effect of lysosomotropic amines.

324. Reversal by concanavalin A of the inhibitory effects of extracellular Ca2+ on pinocytosis in Amoeba proteus.

325. Mesangial cell activation by bacterial endotoxin. Induction of rapid cytoskeletal reorganization and gene expression.

326. Carbachol-activated muscarinic (M1 and M3) receptors transfected into Chinese hamster ovary cells inhibit trafficking of endosomes.

327. Adrenergic influences on the control of blood-brain barrier permeability.

328. Characterization of ramified microglia in tissue culture: pinocytosis and motility.

329. Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor.

330. [Neuropeptides and the hemato-encephalic barrier].

331. Inhibition of pinocytosis by hygrolidin family antibiotics: possible correlation with their selective effects on oncogene-expressed cells.

332. Neutrophil activation through high-affinity Fc gamma receptor using a monomeric antibody with unique properties.

333. Effects of geraniin on morphology and function of macrophages.

334. Diacylglycerols and PMA are particularly effective stimulators of fluid pinocytosis in human neutrophils.

335. Calcitonin and somatostatin immunoreactive cells are present in human bone marrow and bone marrow cells are responsive to calcitonin and somatostatin.

336. Characterization of the cytochalasin D-resistant (pinocytic) mechanisms of endocytosis utilized by chlamydiae.

337. Caffeine, an inhibitor of endocytosis in Dictyostelium discoideum amoebae.

338. The protein kinase C inhibitor H-7 activates human neutrophils: effect on shape, actin polymerization, fluid pinocytosis and locomotion.

339. Reversible mitochondrial swelling in cultured rat hepatocytes exposed to 1,2-dimethylhydrazine.

340. Evidence for a vacuolar-type proton ATPase in Entamoeba histolytica.

341. Resistance of macrophages to 5-fluorouracil treatment.

342. Amitriptyline-induced morphological alterations of the rat blood-brain barrier.

344. Effects of drugs on blood-brain barrier permeability in rats chronically intoxicated by ethanol.

345. Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates.

346. Studies on in vitro chrysotile-pleural mesothelial cell interaction: morphological aspects and metabolism of benzo-3,4-pyrene.

348. Modification of the rate of pinocytosis in arterial smooth muscle cells in culture.

349. Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization.

350. Lysolecithin as a modifier of induced pinocytosis in Amoeba proteus.

Catalog

Books, media, physical & digital resources